Related Experiment Video
Updated: Apr 15, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
Background:
The mechanistic target of rapamycin, (mTOR) kinase plays a pivotal role in controlling critical cellular growth and survival pathways, and its aberrant induction is implicated in cancer pathogenesis. Therefore, suppression of active mTOR signaling has been of great interest to researchers; several mTOR inhibitors have been discovered to date. Ethanol (EtOH), similar to pharmacologic mTOR inhibitors, has been shown to suppress the mTOR signaling pathway, though in a non-catalytic manner. Despite population studies showing that the consumption of EtOH has a protective effect against hematological malignancies, the mechanisms behind EtOH's modulation of mTOR activity in cells and its downstream consequences are largely unknown. Here we evaluated the effects of EtOH on the mTOR pathway, in comparison to the active-site mTOR inhibitor INK128, and compared translatome analysis of their downstream effects in diffuse large B-cell lymphoma (DLBCL).
Results:
Treatment of DLBCL cells with EtOH suppressed mTORC1 complex formation while increasing AKT phosphorylation and mTORC2 complex assembly. INK128 completely abrogated AKT phosphorylation without affecting the structure of mTORC1/2 complexes. Accordingly, EtOH less profoundly suppressed cap-dependent translation and global protein synthesis, compared to a remarkable inhibitory effect of INK128 treatment. Importantly, EtOH treatment induced the formation of stress granules, while INK128 suppressed their formation. Microarray analysis of polysomal RNA revealed that although both agents primarily affected cell growth and survival, EtOH and INK128 regulated the synthesis of mostly distinct genes involved in these processes. Though both EtOH and INK128 inhibited cell cycle, proliferation and autophagy, EtOH, in contrast to INK128, did not induce cell apoptosis.
Conclusion:
Given that EtOH, similar to pharmacologic mTOR inhibitors, inhibits mTOR signaling, we systematically explored the effect of EtOH and INK128 on mTOR signal transduction, components of the mTORC1/2 interaction and their downstream effectors in DLBCL malignancy. We found that EtOH partially inhibits mTOR signaling and protein translation, compared to INK128's complete mTOR inhibition. Translatome analysis of mTOR downstream target genes established that differential inhibition of mTOR by EtOH and INK128 distinctly modulates translation of specific subsets of mRNAs involved in cell growth and survival, leading to differential cellular response and survival.
Insights
Ethanol (EtOH) partially suppresses mTOR signaling and protein translation in diffuse large B-cell lymphoma (DLBCL) cells, unlike complete inhibition by INK128. This differential effect leads to distinct cellular responses and survival outcomes in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aberrant mechanistic target of rapamycin (mTOR) kinase signaling is implicated in cancer pathogenesis.
- Ethanol (EtOH) is known to suppress mTOR signaling non-catalytically, with population studies suggesting a protective effect against hematological malignancies.
- The precise mechanisms of EtOH's modulation of mTOR activity and its downstream effects in cancer cells remain largely unknown.
Purpose of the Study:
- To evaluate the effects of EtOH on the mTOR pathway in diffuse large B-cell lymphoma (DLBCL) cells.
- To compare EtOH's effects with those of the active-site mTOR inhibitor INK128.
- To analyze the downstream effects of EtOH and INK128 on protein translation via translatome analysis.
Main Methods:
- Treatment of DLBCL cells with EtOH and INK128.
- Assessment of mTORC1/2 complex formation and AKT phosphorylation.
- Cap-dependent translation and global protein synthesis assays.
- Microarray analysis of polysomal RNA to compare translatome profiles.
Main Results:
- EtOH suppressed mTORC1 but increased AKT phosphorylation and mTORC2 assembly, while INK128 abrogated AKT phosphorylation.
- EtOH partially suppressed protein translation and induced stress granules, whereas INK128 strongly inhibited translation and suppressed stress granules.
- Both agents inhibited cell cycle, proliferation, and autophagy, but only INK128 induced apoptosis; EtOH and INK128 modulated distinct sets of genes involved in cell growth and survival.
Conclusions:
- EtOH partially inhibits mTOR signaling and protein translation in DLBCL, contrasting with the complete inhibition by INK128.
- Differential inhibition of mTOR by EtOH and INK128 distinctly modulates the translation of specific mRNA subsets.
- These distinct modulations lead to differential cellular responses and survival outcomes in DLBCL malignancy.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Inhibition of Cdk Activity
Inhibition of CDK Activity